| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 18, 2025 | Sep 19, 2025 | C4 Therapeutics, Inc. | CFO | Sell | 47.5 | -2,775 | -1.68% | ✗ | $9.2K |
| Feb 13, 2025 | Feb 18, 2025 | C4 Therapeutics, Inc. | CFO | Sell | 91.3 | +80,678 | 95.55% | ✗ | $20.5K |
| Nov 7, 2024 | Nov 12, 2024 | C4 Therapeutics, Inc. | CFO | Sell | 47.5 | -1,102 | -1.29% | ✗ | $6.7K |
| Sep 18, 2024 | Sep 20, 2024 | C4 Therapeutics, Inc. | CFO | Sell | 46.3 | -1,837 | -2.20% | ✗ | $11.7K |
| Sep 16, 2024 | Sep 17, 2024 | C4 Therapeutics, Inc. | CFO | Sell | 50.0 | -661 | -0.78% | ✗ | $4.2K |
| Feb 13, 2024 | Feb 15, 2024 | C4 Therapeutics, Inc. | CFO | Sell | 90.0 | +35,399 | 75.90% | ✗ | $8.5K |